Failed IVF and a Second Medical Opinion: What to Do Next

Medically reviewed on 11 July 2026 - Dr. Senai Aksoy
Failed IVF and a Second Medical Opinion: What to Do Next

Key Takeaways

Failed IVF is not a dead end — it is a source of clinical information. A useful second opinion starts with retrieving your complete medical file, including embryology reports. Under ESHRE's updated definition, recurrent implantation failure is now assessed through a personalised cumulative success rate rather than a fixed number of attempts. In Turkey, patient rights law guarantees access to that file.


Video: Second Opinion in IVF — Getting Your Medical File Back (5 Points to Check Before You Restart)

Watch Video: Second Opinion in IVF and Getting Your Medical File Back by Dr. Senai Aksoy

(Note: This video features voiceovers and subtitles. You can choose your preferred audio track and subtitles in the video settings on YouTube.)


Why Ask for a Second Opinion After Failed IVF?

A failed IVF cycle is never a neutral event. It affects the couple’s finances, their morale, and a negative result can make the whole process feel like it has stalled. Wanting a second opinion in that situation is entirely reasonable.

That opinion is only as good as the information behind it. Walking into a new doctor’s office without your previous records is a bit like taking your car to a new mechanic and asking them to guess what broke last time: it wastes time, sometimes repeats the same mistakes, and biological time cannot be recovered once it has passed.

Every cycle generates information, even one that ends badly. Repeating the exact same protocol simply because the previous file could not be obtained throws that information away, with no benefit to the patient.

What Is the New Definition of Recurrent Implantation Failure (RIF)?

For a long time, recurrent implantation failure (RIF) was defined rigidly: three consecutive failures, or ten embryos transferred without success. A threshold reached, a diagnosis made — administrative logic more than clinical reasoning.

ESHRE (the European society for reproductive medicine) revised this approach. The fixed threshold has been dropped in favour of a more useful concept: the personalised cumulative success rate.

Attempts are no longer simply counted. The patient’s individual profile is reviewed instead: age, ovarian reserve, embryo quality. If those data put her cumulative chance of pregnancy at around 60% across the full course of treatment, and the result is still negative, a closer look is justified.

That spares two kinds of patient an unnecessary detour. One whose per-attempt odds are naturally lower — older age, reduced ovarian reserve — does not need costly, difficult testing after a single failure. A young patient with high-quality embryos, on the other hand, gets a closer review earlier if the outcome clearly diverges from what was expected, instead of waiting for a third failure.

ASRM (the American society) adds another element: repeated biochemical pregnancies are also factored in. In other words, the cause is not always on the female side — a sperm DNA fragmentation panel is one of the avenues worth considering.

Which Uterine Obstacles and Infections Should Be Checked?

Before restarting a protocol, the uterine cavity deserves a proper review. Several factors can explain a failed cycle independently of embryo quality:

How Do You Judge the Quality of an Embryology Lab?

When you consult for a second opinion, don’t stop at the waiting room. The embryology lab deserves just as much attention — much of the outcome is decided there.

A good lab does not happen by accident: strict ISO standards, filtered air, and stable temperature. These conditions matter almost as much as the embryo’s starting quality, and they show up in the embryology report:

Which Add-On Tests and Treatments Are Actually Evidence-Based?

This is where marketing sometimes creeps into medicine, with add-on tests or treatments offered for every cycle. ESHRE has published a tiered classification to help sort through them:

Option / testESHRE statusWhat to know
Hysteroscopy and tubal surgery🟢 RecommendedUseful for correcting a uterine abnormality or treating a leaking tube.
Parental karyotyping🟢 RecommendedIdentifies possible chromosomal abnormalities in either partner.
PGT-A (embryo screening)🟡 Case-by-caseMay be relevant depending on age or history. For a young patient with no relevant history, the benefit is limited.
ERA test and endometrial scratching🔴 Not recommended routinelyThe strongest studies show no consistent benefit.
Immunotherapies (intralipids, IVIG)🔴 Not recommendedEvidence remains weak; these approaches rely more on belief than on solid proof.

Biology can never be fully predicted. Not even the best lab or the best-calibrated protocol can guarantee that an embryo will implant. But understanding why an attempt did not work requires being able to review it — and that means having access to the file.

In Turkey, Article 16 of the Patient Rights Regulation protects this right. You are legally entitled to request the full set of your records: culture reports, stimulation protocol, and embryology records. If a previous clinic is slow to respond, a written follow-up request is usually the most effective way to assert this right.

These are exactly the elements a serious second opinion will review first, before any decision about the next step.

FAQ

Why did my IVF cycle fail?

Failed IVF can result from chromosomal abnormalities in the embryo, reduced egg or sperm quality, or uterine factors such as hydrosalpinx, polyps, or chronic endometritis that interfere with implantation.

Can I get my complete embryology file?

Yes. In Turkey, Article 16 of the Patient Rights Regulation legally guarantees access to your entire medical file, including embryo development reports.

What is the personalised cumulative success rate in IVF?

Endorsed by ESHRE, this concept replaces the old fixed rule of three consecutive failures. It evaluates your realistic chances of pregnancy based on your age and biological data, to determine when further testing is genuinely useful.

Does hydrosalpinx prevent embryo implantation?

It can interfere with it. Fluid trapped in a blocked tube can flow back into the uterine cavity and disrupt the endometrium, which reduces IVF success rates in some cases.

What tests should I consider after a negative IVF cycle?

A diagnostic hysteroscopy to check the uterine cavity, a biopsy to rule out chronic endometritis, and a sperm DNA fragmentation panel to rule out a male factor are common next steps.

How do you judge the quality of an IVF lab?

A good lab cultures embryos to the blastocyst stage (day 5) and limits cellular fragmentation through well-maintained incubators and strict air-quality protocols that meet ISO standards.

Clinical Note

After thirty years in this field, I still see too many couples arrive at consultation looking almost apologetic for being there. Repeating a protocol with the exact same doses as the previous attempt, simply because the old file could not be obtained, makes no clinical sense. A second opinion only has value if it starts from the facts of the previous cycle, not from a blank page.

— Dr. Senai Aksoy

Request a Case Review

If you would like a structured review of your file rather than another attempt without analysis, you can request a confidential case review. Sharing your stimulation records, embryology results, and transfer history helps us give you a meaningful assessment from the start.

Medical Disclaimer

This article is for general educational purposes and reflects guideline recommendations from professional societies as well as clinical experience. It does not constitute an individual diagnosis, a treatment recommendation, or any promise of a specific outcome. Only a personal evaluation, based on your complete file, can guide the next step in your care.

Sources

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.